Presentaties 2015

De medewerkers van SHM geven met regelmaat presentaties waarin bevindingen uit onderzoek en publicaties worden gepresenteerd. Een groot gedeelte van de presentaties is Engelstalig. Hieronder vindt u een overzicht van de meest recente presentaties.

Presentations:

Posters:

Presentations

Posters

  • Secondary PcP prophylaxis can be safely withdrawn in patients with CD4 counts of 100-200 c/ul and suppressed HIV-RNA
    Kraus D.
  • When to monitor cd4 cell count and HIV-RNA to reduce mortality, AIDS-defining illness, and virologic failure in HIV-infected persons in developed countries 


    Caniglia E.
  • When to start antiretroviral combined therapy in HIV positive individuals aged over 50 
    Lodi S.
  • Evolving trends in causes of death among treated HIV-positive individuals
    Ingle S. 
  • Mortality declining substantially between 1996-2010 among patients starting ART
     
  • Association of non-AIDS morbidity with CD4:CD8 ratio in cART treated individuals, 
    Gras L. 
  • Frailty predicts all-cause mortality, hospital admission and falls in HIV-infected and -uninfected middle-aged individuals
    Kooij, K. 
  • Higher prevalence of hypertension in HIV-infected individuals partially explained by increased waist-hip ration rather than BMI, other traditional risk factors or markers of systemic inflammation
    Van Zoest R.
  • HIV/HCV co-infecte childen and youth on peg-interferon and ribavirin in Europe: treatment outcomes
    Turkova A. 
  • Cascade of care of HIV-1 infected children in the Netherlands
    Smit C. 
  • Durability of first-line antiretroviral therapy (ART) in children in the European Pregnancy and paediatric HIV Cohort Collaboration
    Collins I.
  • Tubercolosis increases long-term risk of mortality due to non-AIDS defining events (NADEs) among HIV-infected persons ons antiretroviral therapy (ART)
    Pettit A. 
  • High alcohol use is associated with non-AIDS-related mortality in the ART-CC
    Ingle S. 
  • Mortality in migrants living with HIV in Western Europe: differences by geographical origin and sex
    Monge S. 
  • Which is the better prognostic marker - CD8 or CD4:CD8 ratio? 
    Trickey A. 
  • Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014
    Van Sighem A. 

Presentations

  • HIV Phylogenetics: Lessons for HIV Prevention
    Fraser C
  • Exposure to Antiretrovirals (ARVs) and Development of Chronic Kidney Disease (CKD)
    Mocroft A, Lundgren JD, Ross M, Fux C, Reiss P, Moranne O, Morlat P, d’Arminio Monforte A, Kirk O, Ryom L, On behalf of the the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group 

Posters

  • ’Test-and-treat’ in the Netherlands
    van Sighem AI, Gras LAJ, Op de Coul ELM, Bezemer DO, Agtmael MA, de Bree G, Reiss P, on behalf of the ATHENA national observational HIV cohort 
  • Decreasing Number of Undiagnosed HIV Infections in the Netherlands 
    van Sighem A, Nakagawa F, De Angelis D, Quinten C, Bezemer D, Op de Coul E, Egger M, de Wolf F, Fraser C, Phillips A
  • Sources of HIV-1 Transmission in the Ongoing, Concentrated HIV Epidemic Among Men Having Sex With Men in the Netherlands Between July 1996 and December 2010
    Ratmann O, van Sighem A, Bezemer D, GavryushkinaA, Reiss P, de Wolf F, Fraser C
  • CD4 Cell Dynamics in HIV-1 Infection Before and After ART: Overview and Determinants
    Cori A, Pickles M, van Sighem A, Gras L, Bezemer D, Reiss P, Fraser C, on behalf of the ATHENA Observational Cohort 
  • Virological Responses to Lamivudine and Emtricitabine in the Nationwide ATHENA Cohort
    Rokx C, Fibriani A, van de Vijver D, Verbon A, Schutten M, Gras L, Rijnders B
  • Risk Factors for Transmission of HCV Among HIVInfected MSM: A Case-Control Study
    Vanhommerig JW, Lambers FA, Schinkel K. Arends JE, Lauw FN, Brinkman K, Gras L, Rijnders BJ, van der Meer JT, Prins M
  • Majority of HCV/HIV-Infected Patients in the Netherlands Remain in Need of Effective HCV Treatment
    Smit C, Arends JE, van der Valk M, Brinkman K, Ammerlaan H, Arend S, Reiss P, Richter C
  • Performance of 4 Tools to Screen for HIV-Associated Cognitive Impairment
    Schouten J, Su T, van Zoest RA, Wit FW, Stolte IG, Winston A, Reiss P, Portegies P, Geurtsen GJ, Schmand BA
  • Association of CD4:CD8 With Cause-Specific Mortality in Patients on Long-Term ART
    May MT, Trickey A, Costagliola D, Reiss P, Moreno S, Gill J, Smith C, Ingle SM, Sterne JA, On behalf of the Antiretroviral Therapy Cohort Collaboration (ART-CC)
  • Impact of Specific Antiretroviral Drugs on Non-AIDS Mortality; the D:A:D Study
    Hatleberg C, Ryom L, Phillips AN, Mocroft A, Reiss P, Law M, Weber R, Dabis F, Lundgren JD, Smith C,  On behalf of the D:A:D Study group
  • Impact of Antiretroviral Drugs on Hypertension in HIV-Positive Persons: D:A:D Study
    Hatleberg C, Ryom L, d’Arminio Monforte A, Fontas E, Reiss P, Kirk O, El-Sadr WM, De Wit S, Lundgren JD, Sabin C, On behalf of the D:A:D Study group
  • Relationship Between Confirmed eGFR and Cardiovascular Disease in HIV-Positive Persons
    Ryom L, Lundgren JD, Reiss P, Ross M, Fux C, Morlat P, Moranne O, Smith C, Sabin C, Mocroft A, On Behalf of the D:A:D Study Group
  • APRI and FIB4: Associated With D-Drug Exposure, Low CD4 Count and Monocyte Activation
    Kooij KW, van Zoest R, Wit FW, Schouten J, Kootstra N, Stolte IG, Prins3 M, Reiss P, van der Valk M, AGEhIV Cohort Study Group
  • Cognitive Performance and Intracerebral Findings in Perinatally HIV-Infected Children
    Cohen S, Caan MW, ter Stege JA, Scherpbier HJ, Kuijpers TW, Reiss P, Geurtsen GJ, Majoie CB, Schmand B, Pajkrt D 

Presentations

  • An update on HIV in the Netherlands
    Reiss P
  • Factors associated with late presentation and advanced disease of HIV in the Netherlands, 1996-2014
    Op de Coul, ELM, van Sighem, AI, Brinkman, K, van Benthem, BH, van der Ende, ME, Geerlings, S , Reiss, P 
  • Cerebral structural and microstructural differences between perinatally HIV-infected children and healthy controls
    Cohen, S, Caan, MWA, Scherpbier, HJ, Kuijpers, TW, Reiss P, Majoie, CBLM, Pajkrt, D
  • Majority of HIV/HCV co-infected patients currently in care in the Netherlands have not yet or not successfully been treated for HCV*
    Smit C, Arends JE, Valk van der M, Brinkman K, Ammerlaan H, Arend S, Reiss P, Richter C
  • Risk factors for sexual transmission of hepatitis C virus: results from the MOSAIC cohort
    Vanhommerig, JW Lambers, FAE, Schinkel, J, Arends, JE, Lauw, FN, Brinkman, K, Gras, LAJ, Rijnders, B, Meer, JTM van der, Prins, M
  • Sources of HIV-1 transmission in the ongoing, concentrated HIV epidemic among men having sex with men in the Netherlands between July 1996 and December 2010
    Ratmann O, Sighem A van, Bezemer D, Gavryushkina A, Reiss P, Wolf F de, Fraser C
  • ‘Test-and-treat’ in the Netherlands
    Sighem, AI van, Gras, LAJ, Op de Coul, ELM, Bezemer, DO, Agtmael, MA, Bree, G de, Reiss, P, on behalf of the ATHENA national observational HIV cohort 
  • HIV infection is independently associated with frailty in middle-aged HIV-infected individuals compared to uninfected controls
    Kooij, KW, Wit, FWNM, Schouten, J, Valk, M van der, Stolte, I, Reiss, P 

Posters

  • The aging HIV-infected population: quantifying the future challenges of HIV clinical care and exploring possible interventions
    Smit, M, Brinkman, K, Geerlings, SE, Smit, C, Thyagarajan, K, Sighem, AI van, Wolf, F de, Hallett, TB
  • Consequences of increased testing and earlier start of therapy on the HIV epidemic among MSM in the Netherlands
    Hengel, R van den, Bezemer, DO, Zwinderman, AH, Wolf, F de, Sighem, AI van 
  • Poorer cognitive performance in perinatally HIV-infected children as compared to healthy socioeconomically matched controls
    Cohen, S, ter Stege, JA, Geurtsen, GJ, Scherpbier, HJ, Kuijpers, TW, Reiss, P, Schmand, B, Pajkrt, D
  • Estimating the Size of the Undiagnosed HIV Population in the Netherlands by Disease Stage
    Sighem, AI van, Nakagawa, F, Bezemer, DO, De Angelis, D, Op de Coul, ELM, Egger, M, Wolf, F de, Fraser, C, Phillips, AN
  • Higher prevalence of hypertension in HIV-infected individuals partially explained by increased waist-hip ratio rather than BMI, other traditional risk factors or markers of systemic inflammation
    Zoest, RA van, Wit, FW, Kooij, KW, Valk, M van der, Schouten, J, Stolte, IG, Kootstra, NA, Wiersinga, WJ, Prins, M, Born, BJH van den, Reiss, P
  • Prevalence and determinants of insufficient work ability in older HIV-positive and HIV-negative workers
    Möller, LM, Brands, R, Sluiter, JK, Schouten, J, Wit, FW, Reiss, P, Prins, M, Stolte, IG
  • Changing patterns of undiagnosed HIV infection in the Netherlands: who benefits most from intensified HIV test and treat policies?
    Op de Coul, ELM, Schreuder, I, Conti, S, Van Sighem, A, De Angelis, D, Xiridou, M, Van Veen, M, Heijne, JCM
  • Dutch GPs adherence to national guidelines promoting HIV testing in populations at higher risk for HIV: bridging database information with clinical practice
    Reukers, DFM, Joore, IKCW, Bergen, JEAM van, Op de Coul, ELM, Donker, GA, Sighem, AI van, Barth, RE, Broek, IV van den
  • Health-related quality of life in perinatally HIV-infected children in the Netherlands
    Stege, JA ter, Cohen, S, Weijsenfeld, AM, Plas, A van der, Kuijpers, TW, Reiss, P, Haverman, L, Pajkrt, D
  • Good SVR12 rates in boceprevir or telaprevir triple therapy in both treatment-naïeve and –experienced patients with HIV/ HCV coinfection in the Netherlands
    Arends, JE, Meer, JTM van der, Posthouwer, D, Kortmann, W, Assen, S van, Reiss, P, Ende, M van de, Brinkman, K, Richter, C, Hoepelman, AIM, Smit, C, Valk, M van der, Schinkel, J 
  • Virological Responses to Lamivudine and Emtricitabine in Combination With Tenofovir and Efavirenz, Nevirapine or Boosted Protease Inhibitors in the Nationwide ATHENA Cohort
    Rokx, C, Fibriani, A, Vijver, DAMC van de, Verbon, A, Schutten, M, Gras, LAJ, Rijnders, BJA, On behalf of the ATHENA National Observational Cohort, SHM
  • Patients' willingness to take separate component antiretroviral therapy regimens for HIV in the Netherlands
    Engelhard, EAN, Smit, C, Vervoort, SCJM, Kroon, F, Brinkman, K, Nieuwkerk, PT, Reiss, P, Geerlings, SE
  • Accentuated CD8+ T-cell senescence is associated with both calendar age and CD8+ T-cell activation in long-term treated HIV-1-infected patients
    Cobos Jiménez, VCJ, Wit, FWNM, Joerink, M, Maurer, I, Harskamp, AH, Schouten, J, Prins, M, Reiss, P, Leeuwen, EMM van, Kootstra, NA

Presentations:

A new method to estimate the first step in the HIV care continuum, Ard van Sighem

IWHOD, Catania, Sicily, Italy, 26-28 March 2015

Presentations:

  • Consequences of increased testing and earlier start of therapy on the HIV epidemic among MSM in the Netherlands
    Van den Hengel R.  

Posters:

  • Secondary PcP prophylaxis can be safely withdrawn in patients with CD4 counts of 100-200 c/μl and suppressed HIV-RNA
    Kraus D. 
  • When to monitor cd4 cell count and HIV-RNA to reduce mortality, AIDS-defining illness, and virologic failure in HIV-infected persons in developed countries
    Caniglia E.  
  • When to start antiretroviral combined therapy in HIV positive individuals aged over 50
    Lodi S.  
  • Evolving trends in causes of death among treated HIV-positive individuals
    Ingle S. 
  • Mortality declining substantially between 1996-2010 among patients starting ART
    Trickey A. 
  • Association of non-AIDS morbidity with CD4:CD8 ratio in cART treated individuals
    Gras L. 
  • Frailty predicts all-cause mortality, hospital admission and falls in HIV-infected and -uninfected middle-aged individuals
    Kooij, K. 
  • Higher prevalence of hypertension in HIV-infected individuals partially explained by increased waist-hip ration rather than BMI, other traditional risk factors or markers of systemic inflammation
    Van Zoest R. 
  • HIV/HCV co-infecte childen and youth on peg-interferon and ribavirin in Europe: treatment outcomes
    Turkova A. 
  • Cascade of care of HIV-1 infected children in the Netherlands
    Smit C. 
  • Durability of first-line antiretroviral therapy (ART) in children in the European Pregnancy and paediatric HIV Cohort Collaboration
    Collins I.
  • Tubercolosis increases long-term risk of mortality due to non-AIDS defining events (NADEs) among HIV-infected persons ons antiretroviral therapy (ART)
    Pettit A. 
  • High alcohol use is associated with non-AIDS-related mortality in the ART-CC
    Ingle S. 
  • Mortality in migrants living with HIV in Western Europe: differences by geographical origin and sex
    Monge S. 
  • Which is the better prognostic marker - CD8 or CD4:CD8 ratio?
    Trickey A. 
  • Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014
    Van Sighem A.  

Presentations:

  • HIV Phylogenetics: Lessons for HIV Prevention
    Fraser C
  • Exposure to Antiretrovirals (ARVs) and Development of Chronic Kidney Disease (CKD)
    Mocroft A, Lundgren JD, Ross M, Fux C, Reiss P, Moranne O, Morlat P, d’Arminio Monforte A, Kirk O, Ryom L, On behalf of the the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group 

Posters:

  • ’Test-and-treat’ in the Netherlands
    van Sighem AI, Gras LAJ, Op de Coul ELM, Bezemer DO, Agtmael MA, de Bree G, Reiss P, on behalf of the ATHENA national observational HIV cohort 
  • Decreasing Number of Undiagnosed HIV Infections in the Netherlands 
    van Sighem A, Nakagawa F, De Angelis D, Quinten C, Bezemer D, Op de Coul E, Egger M, de Wolf F, Fraser C, Phillips A
  • Sources of HIV-1 Transmission in the Ongoing, Concentrated HIV Epidemic Among Men Having Sex With Men in the Netherlands Between July 1996 and December 2010
    Ratmann O, van Sighem A, Bezemer D, GavryushkinaA, Reiss P, de Wolf F, Fraser C
  • CD4 Cell Dynamics in HIV-1 Infection Before and After ART: Overview and Determinants
    Cori A, Pickles M, van Sighem A, Gras L, Bezemer D, Reiss P, Fraser C, on behalf of the ATHENA Observational Cohort 
  • Virological Responses to Lamivudine and Emtricitabine in the Nationwide ATHENA Cohort
    Rokx C, Fibriani A, van de Vijver D, Verbon A, Schutten M, Gras L, Rijnders B
  • Risk Factors for Transmission of HCV Among HIVInfected MSM: A Case-Control Study
    Vanhommerig JW, Lambers FA, Schinkel K. Arends JE, Lauw FN, Brinkman K, Gras L, Rijnders BJ, van der Meer JT, Prins M
  • Majority of HCV/HIV-Infected Patients in the Netherlands Remain in Need of Effective HCV Treatment
    Smit C, Arends JE, van der Valk M, Brinkman K, Ammerlaan H, Arend S, Reiss P, Richter C
  • Performance of 4 Tools to Screen for HIV-Associated Cognitive Impairment
    Schouten J, Su T, van Zoest RA, Wit FW, Stolte IG, Winston A, Reiss P, Portegies P, Geurtsen GJ, Schmand BA
  • Association of CD4:CD8 With Cause-Specific Mortality in Patients on Long-Term ART
    May MT, Trickey A, Costagliola D, Reiss P, Moreno S, Gill J, Smith C, Ingle SM, Sterne JA, On behalf of the Antiretroviral Therapy Cohort Collaboration (ART-CC)
  • Impact of Specific Antiretroviral Drugs on Non-AIDS Mortality; the D:A:D Study
    Hatleberg C, Ryom L, Phillips AN, Mocroft A, Reiss P, Law M, Weber R, Dabis F, Lundgren JD, Smith C,  On behalf of the D:A:D Study group
  • Impact of Antiretroviral Drugs on Hypertension in HIV-Positive Persons: D:A:D Study
    Hatleberg C, Ryom L, d’Arminio Monforte A, Fontas E, Reiss P, Kirk O, El-Sadr WM, De Wit S, Lundgren JD, Sabin C, On behalf of the D:A:D Study group
  • Relationship Between Confirmed eGFR and Cardiovascular Disease in HIV-Positive Persons
    Ryom L, Lundgren JD, Reiss P, Ross M, Fux C, Morlat P, Moranne O, Smith C, Sabin C, Mocroft A, On Behalf of the D:A:D Study Group
  • APRI and FIB4: Associated With D-Drug Exposure, Low CD4 Count and Monocyte Activation
    Kooij KW, van Zoest R, Wit FW, Schouten J, Kootstra N, Stolte IG, Prins3 M, Reiss P, van der Valk M, AGEhIV Cohort Study Group
  • Cognitive Performance and Intracerebral Findings in Perinatally HIV-Infected Children
    Cohen S, Caan MW, ter Stege JA, Scherpbier HJ, Kuijpers TW, Reiss P, Geurtsen GJ, Majoie CB, Schmand B, Pajkrt D